Vicapsys Life Sciences, Inc. (VICP)
0.45
0.00 (0.00%)
USD |
OTCM |
Oct 30, 16:00
Vicapsys Life Sciences 30-Day Average Daily Volume : 2528.57 for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 2528.57 |
| October 29, 2026 | 2528.57 |
| October 28, 2026 | 2524.90 |
| October 27, 2026 | 2611.57 |
| October 26, 2026 | 2607.10 |
| October 23, 2026 | 2645.43 |
| October 22, 2026 | 2645.43 |
| October 21, 2026 | 2467.83 |
| October 20, 2026 | 2106.17 |
| October 19, 2026 | 2106.17 |
| October 16, 2026 | 2106.17 |
| October 15, 2026 | 2089.50 |
| October 14, 2026 | 2089.50 |
| October 13, 2026 | 2176.17 |
| October 12, 2026 | 2176.13 |
| October 09, 2026 | 1930.47 |
| October 08, 2026 | 1930.47 |
| October 07, 2026 | 1747.20 |
| October 06, 2026 | 1498.00 |
| October 05, 2026 | 1322.93 |
| October 02, 2026 | 1322.93 |
| October 01, 2026 | 1140.03 |
| September 30, 2026 | 1106.70 |
| September 29, 2026 | 858.03 |
| September 28, 2026 | 774.67 |
| Date | Value |
|---|---|
| September 25, 2026 | 733.67 |
| September 24, 2026 | 521.60 |
| September 23, 2026 | 492.43 |
| September 22, 2026 | 475.03 |
| September 21, 2026 | 211.70 |
| September 18, 2026 | 211.70 |
| September 17, 2026 | 211.70 |
| September 16, 2026 | 211.70 |
| September 15, 2026 | 125.03 |
| September 14, 2026 | 125.03 |
| September 11, 2026 | 86.70 |
| September 10, 2026 | 86.70 |
| September 09, 2026 | 86.70 |
| September 08, 2026 | 101.53 |
| September 04, 2026 | 101.53 |
| September 03, 2026 | 101.53 |
| September 02, 2026 | 101.53 |
| September 01, 2026 | 101.53 |
| August 31, 2026 | 14.87 |
| August 28, 2026 | 14.87 |
| August 27, 2026 | 14.87 |
| August 26, 2026 | 14.87 |
| August 25, 2026 | 14.87 |
| August 24, 2026 | 14.87 |
| August 21, 2026 | 14.87 |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.853M |
| Oncolytics Biotech, Inc. | 1.292M |
| Sangamo Therapeutics, Inc. | 1.549M |
| Sarepta Therapeutics, Inc. | 2.637M |
| Anixa Biosciences, Inc. | 262363.4 |